Health Catalyst(US:HCAT)2026-03-12 20:58Financial Position - As of December 31, 2025, the company had cash, cash equivalents, and short-term investments of $95.7 million, down from $392.0 million in 2024[467]. - A total of $37.7 million of the delayed draw term loan was drawn upon as of December 31, 2025, with the remaining undrawn amount available for future use[470]. - As of December 31, 2025, total future operating lease payment obligations amounted to $21.0 million, with $3.8 million payable within the next 12 months[481]. - Remaining non-cancelable contractual commitments related to third-party cloud infrastructure agreements totaled $91.4 million, with an aggregate commitment of at least $129.0 million expected to be spent between February 2023 and January 2030[482]. - Restructuring liabilities as of December 31, 2025, were $0.7 million, with the amount payable within the next 12 months[483]. - The company did not have any relationships with unconsolidated organizations or financial partnerships for off-balance sheet arrangements as of December 31, 2025[485]. Debt and Financing - The company entered into a credit agreement on July 16, 2024, providing a five-year term loan facility of up to $225 million, including a $125 million initial term loan fully funded at closing[477]. - The company is required to make quarterly principal payments of 0.25% of the original principal amount starting from the quarter ending December 31, 2024, with a final maturity date of July 16, 2029[479]. Market and Operational Risks - The company faces significant inflationary pressures, particularly in labor and supply costs, which have impacted margins in the health system end market[475]. - The company’s reliance on third-party providers for technology-related services poses risks that could adversely affect its operations[19]. - The company’s ability to attract and retain highly-qualified employees is critical for supporting continued growth in a competitive labor market[17]. - The company’s results of operations have fluctuated significantly in the past, and failure to meet analyst expectations could lead to a substantial decline in stock price[17]. Currency and Interest Rate Risks - The company has not instituted a hedging program for foreign currency exchange risk, but is considering it as international operations expand[472]. - A hypothetical 100 basis point change in interest rates would not have had a material impact on the value of the company's cash equivalents or investment portfolio as of December 31, 2025[469].